NJSH Summer Meeting June 10-11, 2016

Wyndham Hotel & Conference Center

Philadelphia/Mt. Laurel, NJ

Schedule Overview

Friday, June 10 7:30 - 8:30 Registration and Continental Breakfast 8:30 - 12:00 Morning Educational Sessions

with Coffee Break 10-10:30. Vendor Exhibits Open! 12:00-1:00 LUNCH 1:00-4:15 Afternoon Educational Sessions

with Break 3-3:30 in Exhibit Area) 4:30 - 6:00 Cocktail Party in the Exhibit Area Saturday, June 11 7:30 - 8:30 Registration and Continental Breakfast 8:30-12:00 Morning Educational Sessions

with Coffee Break 10-10:30 in Exhibit Area 12:00-1:00 LUNCH 1:00-4:30 Afternoon Educational Sessions

with Break 3-3:30. Last chance to visit vendors!

Vendor Exhibit Hours:

Friday 10AM - 6:00 PM

Saturday 10AM – 3:00 PM

Agenda

FRIDAY, JUNE 10 SATURDAY, JUNE 11 7:30 – 8:30 Registration / Breakfast 7:30 – 8:30 Registration / Breakfast Room A Room B Room A Room B

8:30- 10:00

RNA in Situ Hybridization for Clinical Diagnostics

(Carmen Marshall) ---

Validation & QC of IHC (Joe Myers)

Digital Pathology: 101 (Tim Baradet / Adam

Smith)

It’s Just a Hematoxylin and Eosin Stain, why is

it so hard to get it right? (Debra Siena)

Competency Assessment

(Jan Gardner)

10:00 – 10:30 Break (Vendors Open) 10:00 – 10:30 Break (Vendors Open) Room A Room B Room A Room B

10:30- 12:00

Joe Myers (continued)

Connective Tissue Stains and Modifications for

Automated Image Analysis (Joseph Tamasi)

Debbie Siena (continued )

Jan Gardner (continued)

12:00 – 1:00 LUNCH 12:00 – 1:00 LUNCH Room A Room B Room A Room B

1:00-2:30

Companion Diagnostics for Lung and Breast Cancer

(Lindsay Wrighton) ---

Tumor Immunology - The roles of PD-1 and PD-L1

(Lindsay Wrighton)

How I learned Animal Histology,

According to a Rookie (Calla Walinsky)

--- Introduction to Whole

Slide Scanning, Image & Data

Management & Image Analysis Solutions

(Scott Spear)

Myths, Mysteries and Misconceptions in

Immunohistochemistry (Joe Myers)

Safety Compliance in the Clinical and

Pathology Laboratory (Diana Goodwin)

--- GHS: Global

Harmonization System Labeling

(Donna Chuddley)

2:30 – 3:00 Break 2:30 – 3:00 Break (Last Call for Vendors) Room A Room B Room A Room B

3:00-4:30

Fundamental Techniques & Theories of ISH with a

Comparison to IHC (Thesea Burchette)

Developmental & Reproductive Toxicology

(DART) Testing: A Pharmaceutical

Perspective (Bruce Beyer)

--- Fetal Skeletal Evaluation

(Michele Kanefsky)

New Test Regulations and Their Impact on

‘Advanced’ IHC (Joe Myers)

The Hiring Process (Jan Gardner)

--- Unleashing the Power

of Workflow (Courtney Boccardi)

4:30 – 6:00 Cocktail Party in Exhibit Area See you next Time!

VIR Seminars: How I learned Animal Histology, According to a Rookie (Calla Walinsky 1hr) Introduction to Whole Slide Scanning, Image and Data Management, and Image Analysis Solutions (Scott Spear 30min) Developmental and Reproductive Toxicology (DART) Testing – A Pharmaceutical Perspective (Bruce Beyer 45min) Fetal Skeletal Evaluation (Michele Kanefsky 45min) Clinical Seminars: RNA in Situ Hybridization for Clinical Diagnostics (Carmen Marshall 30min) Validation & QC of IHC (Joe Myers 2.5h) Competency Assessment (Jan Gardner 3hr) Safety Compliance in the Clinical and Pathology Laboratory (Diana Goodwin 1hr) General Application Seminars: Digital Pathology: 101 (Tim Baradet / Adam Smith 1.5hr) Connective Tissue Stains and Modifications for Automated Image Analysis (Joseph Tamasi 1.5hr) Companion Diagnostics for Lung and Breast Cancer (Lindsay Wrighton 45min) Tumor Immunology - the roles of PD-1 and PD-L1 (Lindsay Wrighton 45min) Fundamental Techniques & Theories of ISH with a Comparison to IHC (Thesea Burchette 1.5hr) Myths, Mysteries and Misconceptions in Immunohistochemistry (Joe Myers 1.5hr) New Test Regulations and Their Impact on ‘Advanced’ IHC (Joe Myers 1.5hr) The Hiring Process (Jan Gardner 45min) Unleashing the Power of Workflow (Courtney Boccardi 45min) GHS: Global Harmonization System Labeling (Donna Chuddley 30min)

Abstracts

Friday, June 10th: Morning Sessions Room A: 8:30 - 9:30 RNA in Situ Hybridization for Clinical Diagnostics Carmen Marshall: Mid Atlantic Strategic Account Executive, Advanced Cell Diagnostics New transcriptomic technologies such as microarrays and next generation sequencing (NGS), have enabled new avenues in RNA research. The revelation of RNA’s vast number and diverse role in gene regulation has brought to light the many possibilities for using RNA as an indicator of biological states. The widespread use of transcriptomic profiling in cancer research over recent years has proven that, like protein, RNA is a rich source of clinically valuable biomarkers for diagnosis, prognosis and predicting therapeutic response. The discovery of the “new world” of RNA has sparked an unprecedented drive towards better tools to characterize the complexity of RNA – in terms of quantity, function and spatial distribution. Presenting a vital piece of the puzzle is elucidating the role played by RNA in disease states. Pinpointing the localization of specific RNAs within cells and tissue architecture is an important factor in realizing the link to the detection, localization and validation of RNA as a biomarker.

Room A: 9:30 - 12:00 Validation and Quality Control of Immuno-staining Procedures: A Clinical, Research, and Vendor Perspective Joe Myers, MS, CT (ASCP) QIHC: Senior Technical Sales Specialist, Biocare Medical This presentation is intended to provide a comprehensive overview of the one of most important issues within the field of immunohistochemistry, and assumes a working knowledge of specimen fixation, positive/negative control-material selection, pretreatment procedures, reagent ‘compatibility’ and selection, and essential procedural and documentation requirements. The lecture will also cover such concepts as regulatory guidance on validation (or lack thereof), suggestions for exceeding regulatory agency expectations, and use of automated staining systems. Other issues that will be discussed include staff responsibilities, ongoing quality control, and instrument maintenance. Participants will be encouraged to participate in a ‘question-and-answer’ session at the conclusion of the presentation, as a means of soliciting different opinions and personal preferences. Handout material, including sample forms, comparison tables, and ‘flow’ diagrams will be provided. Room B: 8:30 - 10:00 Digital Pathology 101 Tim Baradet, PhD, HTL (ASCP) QIHC: Adjunct Professor, Drexel University College of Medicine & Adam Smith, BS: Sales Application Scientist, Indica Labs Inc Digital Pathology continues to grow rapidly. Recent FDA rulings on hardware & software bring whole-slide imaging and analysis closer to being a part of daily histopathology lab operations. A short introductory talk will cover: • Project Planning & Optimizing samples • Slide scanners and Scanning • Hardware Set-up for Imaging Analysis • Database & LIMS Integration • Image Analysis • Tissue Macrodissection for NGS • Digital Pathology Analysis: Expectations & Reality Following the introduction, there will be a demonstration of image analysis and management of digital pathology workflow using HALO 2.0, the latest version of Indica Labs’ whole slide image software, introducing a completely new software platform, STRATA.

Friday, June 10th: Morning Sessions (continued) Room B: 10:30 - 12:00 Connective Tissue Stains and Modifications for Automated Image Analysis Joseph Tamasi, PhD: Senior Research Scientist, Bristol-Myers Squibb Connective tissue is abundant and widely distributed providing structural support for the body. It consists of fibers, ground substance and cells. The classification and function of connective tissue is based on the differences in the amounts of these components. While H&E is the most commonly used stain in diagnostic histology, special stains are often necessary to differentiate and evaluate the various components of connective tissue. This presentation will provide an overview of connective tissue focusing on basic staining methods to demonstrate the fibrous elements: collagen, reticular fibers and elastin. In research labs it is often necessary to quantify the relative amounts of these fibers in the tissue of interest. Additionally, modifications of connective tissue stains for automated image analysis will be discussed. Friday, June 10th: Afternoon Sessions Room A: 1:00 - 1:45 Companion Diagnostics for Lung and Breast Cancer Lindsay Wrighton, PhD: Pathology Solutions Specialist, Roche Tissue Diagnostics Healthcare today is in a crisis. The one-size-fits-all treatment strategy widely implemented in cancer therapies is failing the patient community. Historically, nearly 75% of cancer patients are non-responsive to offered therapies. Companion diagnostics focus on pairing a specific antibody with a companion therapy to help target the right patient for the right therapy at the right time. These companion diagnostics stratify patients for custom therapy. Immunohistochemistry and in situ hybridization are powerful tools in identifying these patients as individuals who are likely to respond to treatment. In this manner, the pathology lab can have a direct impact on patient response to therapy. This presentation aims to elucidate the impact of the pathology lab on patient outcomes through the use of companion diagnostics and their cognate therapies.

Room A: 1:45 - 2:30 Tumor Immunology: The roles of PD-1 and PD-L1 Lindsay Wrighton, PhD: Pathology Solutions Specialist, Roche Tissue Diagnostics Immunotherapy is an area of great interest as drugs tied to immunotherapies have demonstrated higher progression-free survival compared to chemotherapy alone in patients with advanced cancers. PD-L1 (program death ligand-1) and its receptor, PD-1 (program death receptor-1), are part of the immune checkpoint pathway and inhibit T-cell receptor signaling. Expression of PD-L1 has been associated with poor prognosis and resistance to therapy in a variety of tumors. This section aims to shed light on the role of PD-L1 in the immune checkpoint pathway, the rationale for PD-L1 testing, and why immunohistochemistry and the pathology lab are crucial in identifying patients for therapy.

Friday, June 10th: Afternoon Sessions (continued)

Room A: 2:30 - 4:15 Fundamental Techniques & Theories of ISH with a Comparison to IHC Theresa Burchette, BS, MT, HTL (ASCP): Strategic Business Manager, Dako/Agilent In situ hybridization (ISH) is a diagnostic technique currently used in molecular laboratories. In recent years this ISH technique has been migrating more towards the anatomical pathology laboratories. This migration is largely due to the use of ISH on FFPE tissue for detecting over expression of genes and virus, along with new easy to use probes and detection systems. ISH has also been popularized by the use of the combination of FDA approved in situ hybridization and Immunohistochemistry detection systems to determine the proper diagnosis and treatment for the patient. Molecular techniques, such as in situ hybridization, deal with targeting nucleic acids, the steps preceding the biological process of making of a protein. The Immunohistochemistry technologists, who deal with detecting proteins in tissue, may be unfamiliar with the molecular process and the techniques used in detecting molecular elements in the tissue. With a little molecular knowledge any technologist will find that In Situ Hybridization is similar to doing Immunohistochemistry and will be able to expand their expertise in this area. Room B: 1:00 - 2:00 How I Learned Animal Histology, According to a Rookie Calla Walinsky: Study Coordinator, Envigo Learning Histology is an art form, especially for a recent college graduate with no prior exposure. This presentation will take you through how a novice Trainee Technician learned the art of Histology, by training and using prior knowledge of Anatomy and Science, and the advancement of that trainee technician to Senior Technician within a short time. It will also address ideas and problems faced when learning new tasks such as Grossing different animal species, Processing, Embedding, Microtoming and Staining, as well as explain how I overcame and succeeded at competently performing those tasks all in under 3 years. Recently, I have undertaken the title Study Coordinator, so I will also include some information on how to successfully understand protocols, SOP’s and create documents for the lab. This will help drive home the point that anyone can learn histology; all that is needed is the understanding of the process, how to troubleshoot, and think about the whole picture.

Room B: 2:00 - 2:30 Introduction to Whole Slide Scanning, Image and Data Management, and Image Analysis Solutions Scott Spear, BS: Pathology Imaging Specialist, Leica Biosystems During this presentation, the audience will become familiar with different types of Whole Slide Scanners. They will gain an understanding of key features to consider when looking at an imaging and Data management solution. Lastly, basic concepts of image analysis will be discussed and a few examples will be demonstrated.

Room B: 2:30 - 3:30 Developmental and Reproductive Toxicology (DART) Testing – A Pharmaceutical Perspective Bruce Beyer, PhD, DABT: Director, Preclinical Safety, Sanofi U.S. Inc As part of the nonclinical safety assessment of pharmaceuticals, developmental and reproductive toxicity testing is required to support different phases of clinical development. The purpose of DART testing is to identify potential hazards for human reproductive function and development, and to assess each different phase of the reproductive cycle and development. These studies typically consist of studies of fertility and early embryonic development in one species (usually the rat), embryo-fetal development in two species (usually the rat and rabbit), and pre- and postnatal development in one species (usually the rat). The presentation will cover the rationale for testing, as well as the most common DART study designs.

Friday, June 10th: Afternoon Sessions (continued) Room B: 3:30 - 4:00 Fetal Skeletal Evaluation Michele Kanefsky, AS, HT (ASCP): Laboratory Technician, Dupont Haskell Global Centers In the non-clinical safety assessment of pharmaceuticals and chemicals, the aim of reproductive toxicity studies is to reveal any effect of a substance on mammalian reproduction. As part of these studies, the assessment of fetal development and growth is performed by detailed macroscopic soft tissue and skeletal examinations of fetuses in the rat and rabbit. These fetal pathology examinations are designed to detect developmental and structural abnormalities and are performed by a fetal morphologist. The rat fetal skeletal specimens are commonly stained with either alizarin red S to stain bone or in combination with alcian blue to stain bone and cartilage referred to as double staining technique. Both staining methods produce clear and articulated specimens which can be easily and fully assessed. This presentation will provide an overview of the fetal skeletal staining processes and the fetal skeletal evaluation necessary to meet regulatory requirements for reproductive safety assessment studies.

Saturday, June 11th: Morning Sessions Room A: 8:30 - 12:00 It’s Just a Hematoxylin and Eosin Stain, why is it so hard to get it right? Debra Siena, HT (ASCP) QIHC: Technical Support Manager, StatLab Medical Products Hematoxylin and Eosin staining has been around for over a hundred years and is one of the most automated stains in the histology laboratory with few labs making their own reagents or stains from scratch and yet there are still questions about how to troubleshoot the H&E stain quite frequently on HistoNet. In this workshop, the basics on Hematoxylin and Eosin staining will be presented so that when things do go awry that the lab will be able to quickly and confidently get to the bottom of the issues quickly. The history of H&E stain will be covered briefly, as well as guidelines for all the steps in the process. Along the way, we will also review how to judge what a good Hematoxylin and Eosin stained slide should look like and what pre-stain processes may be hindering your ability to achieve great stains. Lastly, Quality Control (QC) as well as Quality Assurance (QA) processes will be discussed that can be incorporated into your lab to make sure that the lab is consistently achieving the goal of a correctly stained H&E slide each and every time.

The NJSH would like to thank the following vendors for additional donations and sponsorships…

Saturday, June 11th: Morning Sessions (continued) Room B: 8:30 - 12:00 Competency Assessment Jan Gardner, MBA, HT (ASCP): Director of Laboratory Services, Palestine Regional Medical Center The organization’s most valuable asset is the employee. Organizations cannot afford staff whose skills or competencies do not meet the requirement to perform their job duties. A well-designed competency assessment tool is an ongoing process that measures continually improving, building knowledge and developing skills by addressing areas for improvement. Are you challenged to assess, demonstrate and maintain the knowledge and skill of the histology staff through competency assessment? Federal regulations such as Clinical Laboratory Improvement Amendments (CLIA), College of American Pathologist (CAP) and The Joint Commission (JC) provide standards for competency testing of personal which are to be measurable. This measurable tool must address pre-analytical, analytical and post-analytical processes through direct observation of person’s ability to perform required activities and assessment of the employee’s learning needs. The manager or supervisor evaluates and measures the employee’s job performance and responsibilities as defined in the job description to determine the employee’s knowledge and skill for various duties. How do you define competency and how do you measure if the staff is performing their job duties accurately? This workshop will examine regulatory standards and methods that can be utilized and gather data to create a competency assessment program to fit the organizational needs. This workshop will examine regulatory laws, laboratory accreditation agencies and a basic guide of essential functions to prepare and identify a measurable competency assessment. A well-developed measurement tool will provide the manager with data to demonstrate the histologist work performance or tool to develop a work improvement process.

Saturday, June 11th: Afternoon Sessions Room A: 1:00 - 2:30 Myths, Mysteries and Misconceptions in Immunohistochemistry Joe Myers, MS, CT (ASCP) QIHC: Senior Technical Sales Specialist, Biocare Medical This presentation is intended to provide participants with an overview of several concepts within the field of immunohistochemistry that are often misunderstood, particularly by inexperienced practitioners. It is based on the experience gained by the speaker over the course of nearly 30 years in the field of anatomic pathology. In addition to providing scientific and/or administrative clarification of these myths, mysteries, and misconceptions, this presentation should stimulate participants to take a closer at the practices within their own laboratories and, possibly, seek additional relevant education. Room A: 3:00 - 4:30 New Laboratory-Developed Testing Regulations and Their Impact on ‘Advanced’ IHC Joe Myers, MS, CT (ASCP) QIHC: Senior Technical Sales Specialist, Biocare Medical This presentation is intended to provide participants with a comprehensive review of relatively new (and currently DRAFT) regulations governing laboratory-developed tests (LDTs). Unlike traditional test-classification schemes, where a test’s complexity determines what validation, quality control, instrumentation-related and personnel requirements must be met, classification of LDT’s is based on risk (of ‘harm’ to patients when improperly implemented) and will require labs to behave in the same manner as medical device manufacturers (MDMs) have for many years. Just as the U.S. FDA – the agency responsible for regulating LDTs – requires lab-reagent/instrument vendors to meet very specific criteria before related products are approved, these new regulations will require individual labs to behave like MDMs before testing procedures are approved. One of the most important aspects of LDT regulations is just how they will apply to IHC/ISH labs – which more often than not employ so-called ‘closed’ (automated) systems – which not well known at this time; this situation will, undoubtedly, involve ‘heated’ input from participants.

Saturday, June 11th: Afternoon Sessions (continued) Room B: 1:00 – 1:45 Safety Compliance in the Clinical and Pathology Laboratory Diana Goodwin, BS, HT (ASCP) QIHC: Anatomic Pathology Supervisor and Laboratory Safety Officer, University Medical Center of Princeton at Plainsboro Clinical laboratories are mandated by several regulatory agencies to provide guidelines, policies, and standard operating procedures related to the safety of both employees and patients and their visitors. These include The Joint Commission, the College of American Pathologists, OSHA, the CDC and the state. Policies and procedures are required for biological and chemical hazards, fire prevention and protection, electrical safety, radiation safety, environmental safety, waste disposal and ergonomic safety. In this presentation, we will review the JC, CAP and OSHA requirements for biological, chemical and ergonomic safety. Required components of standard operating procedures will be discussed and examples provided. Also provided will be examples of documentation formats for required record-keeping and online resources. Room B: 1:45 – 2:30 GHS: Global Harmonization System (GHS) Labeling Donna Chuddley, BS, CLA, HT (ASCP) QLS: Consultant, Self-Employed This presentation will provide a history of the GHS labeling according to the "purple book" which describes the classification and labeling of chemicals including those under the OSHA Hazard Communication Standard.

Room B: 3:00 – 3:45 The Hiring Process Jan Gardner, MBA, HT (ASCP): Director of Laboratory Services, Palestine Regional Medical Center An organization’s most valuable asset is its employees. Organizations cannot afford staff whose skills or competencies do not meet the requirements necessary to perform their job duties. Selecting the right candidate requires the interviewer to be prepared with the tools needed to determine the candidate’s qualifications. This presentation will define the steps to take to prepare for the interview process by developing questions designed to assess a candidate’s strengths, weaknesses and suitability for the job and assist you in making the best hiring decision. A good employee is 95% of a leader’s success. A poor hiring decision can cost an organization the equivalent of 1 year’s salary. At the end of this session, participants will have the knowledge to develop a successful hiring process.

Room B: 3:45 - 4:30 Unleashing the Power of Workflow Courtney Boccari, MA: Territory Account Manager, Thermo Fisher Scientific Labs are challenged to provide more value while reducing costs and improving quality. In the USA: Reimbursement reductions and ACA; Europe: Reduced budgets and greater competition in nationalized services; APAC: consolidation and upgrades (e.g., tier 2 to tier 3 in China). Technology has already provided great efficiency and accuracy gains: on demand cassette and slide printing, tissue processors reagent management and automatic reagent rotation based on quality. Local area support wishes to continue these efforts with an emphasis on the application of Lean principles to the lab workflow. This presentation will define current state, with “An eye for waste”, and provide the recommendations and benefits of bringing Lean tools to the lab. This workflow evaluation can be seen in the program, “Lean Tools for the Lab, an Example of Workflow Analysis”, that was piloted in 2015 with two large lab groups. As a result of laboratories looking to eliminate waste and reduce costs while driving the highest quality and shortest lead-time in their processes, vendors will continually work to introduce new products that will follow to continue the drive to make our laboratory and employees more efficient.

VENDOR EXHIBIT PREVIEW...

Cen-Med Enterprises

Thermo Scientific

General Data Healthcare

Dako, Agilent Pathology Solutions

Biocare Medical

Avantik Biogroup

Poly Scientific R&D Corporation

Polysciences, Inc

Statlab Medical Products

Tech One Biomedical Services

Azer Scientific

Roche Tissue Diagnostics

Sakura Finetek USA, Inc.

Electron Microscopy Sciences

Vendor support allows us to bring quality education at an affordable price to our members.

Please be sure to stop by their exhibits and show

your appreciation!

Hotel Information Wyndham Philadelphia Mount Laurel Address: 1111 NJ-73, Mt Laurel, NJ 08054 Phone: (856) 234-7000 RATES & RESERVATIONS The hotel is offering discounted room rates of $149.00/night. This rate does not include the 7% sales tax and 8% occupancy tax. Attendees must make reservations by April 25th and mention the NJSH in order to get the reduced room rate.

Registration Information

Registration is available online at the NJSH web site at www.njsh.org/njsh. Click the link for additional information to access the registration form. Payment may be made online via PayPal. If you prefer, please mail the form below to the address provided with your check. Pre-registration is encouraged. Walk-ins will be accepted as space permit. Meeting Registration Fees Includes: Continental Breakfast, entrance to the vendor exhibits, buffet lunch, AM & PM breaks, and the cocktail party in the exhibit hall Friday evening. Please Note: There will be NO refunds on cancellations AFTER May 30th, 2016.

The first 80 registrants will receive a free tote bag from Newcomer Supply!

More Information

Continuing Education Units will be awarded for approved educational sessions. Please Note: Attendees track their workshops on an NSH provided "Attendee Contact Hour Tracking Sheet" during the event. All contact hour records are maintained through the NSH Contact Hour Portal, ce.nsh.org. About a week following the event attendees log into the Contact Hour Portal and self-report the sessions they attended. Attendees can then print their contact hour certificates immediately. Participants are responsible to obtain their own CEU Certificates by applying on the NSH website. Please do not contact the NJSH for certificates.

Complimentary hors d’oeuvers will be served during the Cocktail Reception, Friday June 10th from 4:30 to 6:00 PM in the Exhibit Area with. Cash bar will be available. For general meeting questions contact: Michele French at 609-818-3278 or michele.french@bms.com

For registration questions contact: Michele Kanefsky at mybell1367@verizon.net

NJSH Summer Meeting Registration Form

Mail in Registration Deadline: May 20th

NAME: ______________________________________________ MAILING ADDRESS: ___________________________________________ ___________________________________________ PHONE NUMBER: ____________________________________ WORKPLACE: _______________________________________ Please provide your E-MAIL address to receive confirmation of your registration:

_____________________________________________

Put an X in each room you would like to attend. Choose only one room/session for each slot.

Session: Time: Room:

A B Friday AM 8:30-12:00

Friday PM 1:00-2:30

3:00-4:30

Saturday AM 8:30-12:00

Saturday PM 1:00-2:30

3:00-4:30

Please circle total due: Registration Fees NJSH Member* Non-Member Student

Both Days $180 $200 $60 Full Day $95 $110 $40

Per Half Day $50 $60 $20 * Please check your membership status on the NJSH website. Do you plan to attend the Friday Cocktail Party? Please circle one: YES NO The Cocktail Party is FREE to paid meeting registrants. You may bring a guest for an additional fee of $25.00. Do you plan to bring a guest? Please circle one: YES NO Please make your check payable to NJSH and mail with your Registration Form to:

NJSH Meeting Registration

P.O. Box 6792 Lawrenceville, NJ 08648

The New Jersey Society for Histotechnology

invites you to attend

the NJSH Summer Meeting June 10 – 11, 2016

Wyndham Philadelphia-Mount Laurel 1111 Route 73 North Mount Laurel, NJ 08054

Please Join Us for this Fantastic Educational Event!

NJSH P.O. Box 6792 Lawrenceville, NJ 08648

Postage

Mailing Label